| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064662 Agonists having a biphenyl moiety in combination with an amide linkage at the core of the structure enhances selectivity for S1P1 receptor without causing hypotension or bradycardia; transplant rejection, autoimmune diseases; 2-Amino-N-[4-(biphenyl-4-yloxy)-phenyl]3-hydroxy-2-methyl-propionamide |
| 03/13/2008 | CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | CA2660757A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines |
| 03/12/2008 | EP1897872A1 Activator for peroxisome proliferator-activated receptor |
| 03/12/2008 | EP1896435A1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors |
| 03/12/2008 | EP1896434A1 SUBSTITUTED HETEROARYL AMIDE MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NFkB ACTIVITY AND USE THEREOF |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/12/2008 | EP1128830B1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| 03/12/2008 | CN101142212A 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 03/12/2008 | CN101139325A 2-(3-cyano-4-isobuoxy phenyl)4-methyl-5-thiazole aminic acid crystal and preparation method thereof |
| 03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
| 03/11/2008 | US7342117 (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]-acetanilide; free base forms; stability; moisture resistance |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7341993 Cross-linked glycopeptide—cephalosporin antibiotics |
| 03/11/2008 | CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |
| 03/06/2008 | WO2008027932A2 Cytochrome p450 oxidase inhibitors and uses thereof |
| 03/06/2008 | WO2008027539A1 Insecticidal n-substituted (2- sudstituted-1,3-thiazol) alkyl sulfoximines |
| 03/06/2008 | WO2008027073A1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines |
| 03/06/2008 | WO2008025870A1 Compositions useful especially for treatment or prevention of metabolic syndrome |
| 03/06/2008 | WO2007149829A3 Therapeutic compounds |
| 03/06/2008 | US20080058397 Therapeutic substituted hydantoins and related compounds |
| 03/06/2008 | US20080058394 Insecticidal N-substituted (2-substituted-1,3-thiazol)alkyl sulfoximines |
| 03/06/2008 | US20080058390 1-(6-substituted-pyridin-3-yl)cycloalkyl sulfoximines; controlling invertebrates, particularly aphids and other sucking insects; resistance to the old insecticides as DDT, carbamates, and organophosphates |
| 03/06/2008 | US20080058389 Carboxamides |
| 03/06/2008 | US20080058387 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 03/06/2008 | US20080058380 2-{[2-(3,5-difluorophenyl)acetyl]amino}-N-{5-[2-(isopropoxymethyl)phenyl]-1,3-thiazol-2-yl}propanamide; neuroprotectant; neurodegenerative diseases: Alzheimer's and Parkinson's disease, Down syndrome, amyloid angiopathy and cerebrovascular disorders |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | CA2661873A1 Cytochrome p450 oxidase inhibitors and uses thereof |
| 03/06/2008 | CA2661517A1 Insecticidal n-substituted (2-substituted-1,3-thiazol)alkyl sulfoximines |
| 03/06/2008 | CA2661480A1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines |
| 03/05/2008 | EP1894929A1 Process for producing thiazolidinedione compound and production intermediate thereof |
| 03/05/2008 | EP1894920A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient |
| 03/05/2008 | EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists |
| 03/05/2008 | EP1893582A2 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| 03/05/2008 | EP1893245A2 Radiolabeled-pegylation of ligands for use as imaging agents |
| 03/05/2008 | EP1893212A2 Multicyclic compounds and methods of their use |
| 03/05/2008 | CN101137660A Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 03/05/2008 | CN101137653A Thiazole-4-carboxamide derivatives as MGLUR5 antagonists |
| 03/05/2008 | CN101137631A Heteroaromatic glucokinase activators |
| 03/05/2008 | CN101137627A Process for the preparation of substituted benzoxazole compounds |
| 03/05/2008 | CN101137363A [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/05/2008 | CN101134749A New method for synthesizing rubber vulcanization accelerator CZ |
| 03/05/2008 | CN101134748A Method for producing rubber vulcanization accelerator DM |
| 03/05/2008 | CN101134744A Heterocyclic compound, the function, organic semiconductor material and electronic or opto-electrical element |
| 03/04/2008 | US7339065 Design and synthesis of optimized ligands for PPAR |
| 03/04/2008 | US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants |
| 03/04/2008 | US7338956 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/28/2008 | WO2008024302A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008023610A1 External reparation for skin |
| 02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| 02/28/2008 | WO2007017510A3 Isophthalic acid diamides for treating alzheimer's disease |
| 02/28/2008 | US20080051577 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/28/2008 | US20080051446 Heterocyclocarboxamide Derivatives |
| 02/28/2008 | US20080051436 Use of Acylaminothiazole Derivatives as Therapeutic Agents |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051423 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/28/2008 | US20080051418 Arylalkanoic Acid Derivative |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080051374 ophthalmically acceptable for reducing intraocular pressure |
| 02/28/2008 | CA2661440A1 Compounds for treating proliferative disorders |
| 02/27/2008 | EP1891948A1 Treatment of neurological and neuropsychological disorders |
| 02/27/2008 | EP1891028A1 Non-peptidic inhibitors of akap/pka interaction |
| 02/27/2008 | EP1891027A1 Processes for the preparation of stable polymorphic form i of ritonavir |
| 02/27/2008 | EP1890695A2 Use of 2,5-disubstituted thiazol-4-one derivatives in drugs |
| 02/27/2008 | EP1778627B1 Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | CN101130526A Aryl carbonyl derivatives as therapeutic agents |
| 02/27/2008 | CN101130525A [inverse]-beta- farnesene analogue, preparing method and application of the same |
| 02/27/2008 | CN100371328C Substituted benzoyl carbamidine derivative, its preparation method and medical uses |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/26/2008 | US7335778 Intermediate for biotin and process for producing the same |
| 02/26/2008 | US7335776 Remedies for depression containing EP1 antagonist as the active ingredient |
| 02/26/2008 | US7335775 Effector conjugates, process for their production and their pharmaceutical use |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335674 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335652 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and\or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination |
| 02/21/2008 | WO2008022281A1 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 02/21/2008 | WO2008021871A2 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/21/2008 | WO2007103456A3 Piperazine and piperidine biaryl derivatives |
| 02/21/2008 | WO2007101935A3 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 02/21/2008 | WO2007010222A3 Therapeutic agents |
| 02/21/2008 | US20080045721 Thiazole-oxime chemical intermediates to cephalosporin-linked vancomycin derivatives which have use against antibiotic-resistant bacteria including methicillin-resistant Staphylococci aureus (MRSA) |
| 02/21/2008 | US20080045720 Reacting a naphthalenecarboxylic acid halide compound with ammonium acetate in a solvent such as tetrahydrofuran; high yield and at low cost; as chemical intermediates in producing dyes such as azo dyes, medical and agricultural chemicals |
| 02/21/2008 | US20080045556 4-[2-(4,4-Dimethyl-2-thioxo-1,3-oxazolidin-3-yl)-1,3-thiazol-4-yl]benzonitrile; progesterone receptor (PR); contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy |
| 02/21/2008 | US20080045545 3-{[(4-pyrazol-1-yl-benzyl)-(pyridine-3-sulfonyl)-amino]methyl}phenoxy)-acetic acid isopropyl ester; for reducing intraocular pressure in treating glaucoma, in a mammal |
| 02/21/2008 | US20080045524 Selective NPY (Y5) antagonists |
| 02/21/2008 | US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer |
| 02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2008 | US20080045483 such as 4-{2-[2-(4-chlorobenzenesulfonylamino)phenyl]ethyl}benzoic acid; hyperglycemic agents |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |